Prenatal Gene Editing for Neurodevelopmental Disease: Ethical Considerations
November 12, 2024
Lunch will be provided for in-person attendees. Neurodevelopmental diseases (NDDs) are notoriously difficult to treat because clinical symptoms stem from developmental processes that begin before birth. Prenatal gene editing could fill the treatment gap for NDDS by targeting and permanently correcting the genetic variants that underlie these pathogenic developmental...